<DOC>
	<DOCNO>NCT02269306</DOCNO>
	<brief_summary>The purpose study determine whether Visceral fat area criterion assess initial screening could predict response ovulation induction clomiphene citrate ( CC ) patient polycystic ovary syndrome ( PCOS ) .</brief_summary>
	<brief_title>Predictors Ovarian Response During Clomiphene Citrate Ovulation Induction Patients With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>The study carry 150 patient PCOS . Initial CC dose 50 mg daily 5 day start cycle day 3 . In case absent response , dos increase 100 150 mg daily subsequent cycle . First ovulation CC use end point.Statistical method Distribution characteristic patient present mean Â± SD . We use Mann-Whitney U test exploratory comparison initial parameter responder nonresponders . The univariate multivariate relation response CC assess use logistic regression analysis . Backward stepwise elimination use multivariate logistic analysis prediction patient CRA , P &lt; 0.10 use cut-off level elimination non-significant predictor prognostic model . The area receiver operate characteristic ( ROC ) curve ( AUC ) use assess discriminative ability logistic model . SPSS statistical package version 17 ( SPSS Inc. , Chicago , IL ) MedCalc Software version 12.4 , ( Ostend , Belgium ) employ data analysis .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Anovulation</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>The study include 150 infertile woman ( age 18 40 year ) PCOS diagnose presence least two follow [ 15 ] : 1 . Clinical hyperandrogenism : Hirsutism acne vulgaris and/or biochemical hyperandrogenism ( total testosterone &gt; 88 ng/dl DHEAS &gt; 275 ug/dL ) [ 16 ] . ( 2 ) Menstrual and/or ovulatory disturbance , mainly oligomenorrhea ( interval vaginal bleeding &gt; 35 day &lt; 6 month ) amenorrhea ( bleed interval &gt; 6 month ) . ( 3 ) Polycystic ovary visualize transvaginal ultrasound ( either 12 follicle measure 29 mm diameter increase ovarian volume &gt; 10 cm3 ) . Patients one criterion exclude ; Age &lt; 18 year &gt; 40 year , body mass index ( BMI ) &lt; 18.5 kg/m2 &gt; 35 kg/m2 , pregnancy , endocrine disorder , systemic disease , current previous ( within last 3 month ) use oral contraceptive , glucocorticoid , antiandrogens , ovulation induction dopaminergic agent , use antidiabetes , antiobesity drug history tubal ovarian surgery .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>PCOS</keyword>
	<keyword>clomiphene citrate</keyword>
	<keyword>AMH</keyword>
	<keyword>visceral fat area</keyword>
	<keyword>HOMA-IR</keyword>
</DOC>